// App-Quantinova.ai

: Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens

Researchers

Presenter

  • Alexandra Rezazadeh

Principal Investigators

  • Gemlyn George

  • Nicole Pearl

  • Cole McCoy

  • Felicia Zook

  • Benjamin Jung

  • Aschenbrenner Emilie

  • Mindy Waggoner

  • Sameem Abedin

  • Lyndsey Runaas

  • Laura C. Michaelis

  • Karen-Sue B. Carlson

  • Lisa Baumann Kreuziger

  • Ehab L. Atallah

Medical Centers

  • The Medical College of Wisconsin, Milwaukee, WI

  • The Medical College of Wisconsin, Milwaukee, WI

  • Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

  • Medical College of Wisconsin, Froedert Cancer Center, Milwaukee, WI

  • BloodCenter of Wisconsin, Menomonee Falls, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved